Navigation Links
Fat-Fighting Chemical Holds Promise
Date:8/27/2009

But research on 'fatostatin' is still in early stages

THURSDAY, Aug. 27 (HealthDay News) -- Researchers report that a manmade chemical appears to have the power to turn off fat production, potentially turning it into a weapon against obesity.

Fat mice injected with the chemical, known as fatostatin, didn't get fatter and developed lower cholesterol and blood sugar levels, the research team said.

But don't run out and ask your doctor for a fatostatin shot quite yet. While the chemical holds promise as a "starting point" to develop new drugs, it's not a drug itself, said study co-author Motonari Uesugi, a researcher at Kyoto University in Japan.

Still, there's the matter of those mice who didn't put on extra ounces. "When fatostatin is injected, mice did not get fat even when they ate a lot," Uesugi said. Furthermore, "we did not see any obvious side effects or toxic effects," he added.

Researchers have long been trying to find a pill to help people fight obesity. Anti-obesity drugs do exist, but they have side effects that convince some patients to stop using them.

Uesugi said his laboratory has samples of 30,000 chemicals and is testing them on human and mouse cells. The molecule in question, fatostatin, appeared to stop fat production by turning certain genetic switches.

In the new study, published in the Aug. 28 issue of the journal Chemistry and Biology, the researchers report that the chemical prevented obese mice from getting fatter even when they could eat whatever they wanted.

But Uesugi said injection of a drug isn't a good option for people with chronic metabolic diseases, such as those that cause obesity. More research needs to be done to develop a drug that could be taken by mouth and is safe for people, he said.

In regards to safety, fatostatin's "activity on 63 genes, many of which have nothing to do with fat synthesis, raises questions about potential side effects, particularly if the chemical is ingested over many years," noted Dr. Nicholas H.E. Mezitis, assistant professor of clinical medicine at Columbia University College of Physicians and Surgeons, who is familiar with the study findings.

For the moment, it is "still challenging" to develop drugs that safely treat obesity, said metabolism researcher Dr. Tae-Hwa Chun, who also is familiar with the report.

A positive finding "in cells and rodents does not always lead to the development of safe and effective drugs for patients," added Chun, an assistant professor at the University of Michigan who specializes in metabolic syndrome.

Still, Chun said, there's promise in the idea of targeting genetic switches that turn on fat production, as fatostatin appears to do.

More information

Learn more about obesity from the National Institutes of Health.



SOURCES: Motonari Uesugi, Ph.D., researcher, Kyoto University, Japan; Tae-Hwa Chun, M.D., Ph.D., assistant professor, University of Michigan, Ann Arbor; Nicholas H.E. Mezitis, M.D., assistant professor of clinical medicine, Columbia University College of Physicians and Surgeons, New York City; Aug. 28, 2009, Chemistry and Biology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chemical culprit in popcorn workers lung identified
2. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
3. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
4. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
5. Low Doses of Red Wine Chemical May Fight Diabetes
6. National Academies advisory: genes and toxic chemicals
7. Genomic technologies to identify toxic chemicals should be developed
8. Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
9. American Chemical Societys Weekly Presspac -- Oct. 17, 2007
10. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
11. Brains Reward Chemical May Help Spur Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fat-Fighting Chemical Holds Promise
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: